Source comparison
Side-by-Side Comparison
Mechanism T-cell maturation; DC activation; TLR signaling; cytokine modulation VEGF, EGF, FGF upregulation; NO modulation; growth factor pathways Evidence Grade A Structure 28-amino acid thymic peptide 15-amino acid gastric pentadecapeptide Primary Function Im
This comparison does not assign a generated winner or score.
- Mechanism
- T-cell maturation; DC activation; TLR signaling; cytokine modulation
- VEGF, EGF, FGF upregulation; NO modulation; growth factor pathways
- Evidence Grade
- A
- Structure
- 28-amino acid thymic peptide
- 15-amino acid gastric pentadecapeptide
- Primary Function
- Immune modulation and enhancement
- Tissue healing and repair
- Route
- Subcutaneous injection
- Subcutaneous (local/systemic) or oral
- Typical Dose
- 1.6 mg SC twice weekly
- 250 - 500 mcg/day
- Half-Life
- ~2 hours
- ~4 hours
- Best For
- Immune support, hepatitis, cancer adjuvant, infection recovery
- Tendon, ligament, gut, nerve healing
- FDA Status
- Not FDA-approved; approved in 35+ countries; orphan drug designation
- Not FDA-approved; research compound
- Cost (research grade)
- $$$
- $